The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
 
 
Consulting or Advisory Role - Amgen; GlaxoSmithKline/Tesaro
Speakers' Bureau - AstraZeneca; Clovis Oncology; GlaxoSmithKline/Tesaro; PharmaMar; Roche
Travel, Accommodations, Expenses - GlaxoSmithKline/Tesaro; PharmaMar
 
Consulting or Advisory Role - AstraZeneca; Tesaro
Speakers' Bureau - AstraZeneca; Tesaro
Travel, Accommodations, Expenses - MSD; Roche; Tesaro
SIENDO/ENGOT-EN5: A randomized phase III trial of maintenance with selinexor/placebo after combination chemotherapy in patients with advanced or recurrent endometrial cancer.
 
Ignace Vergote
Consulting or Advisory Role - Amgen (Inst); AstraZeneca (Inst); Carrick Therapeutics (Inst); Clovis Oncology (Inst); Debiopharm Group (Inst); Genmab (Inst); GlaxoSmithKline (Inst); Immunogen (Inst); Medical University of Vienna (Inst); Millennium (Inst); MSD Belgium (Inst); Octimet (Inst); Oncoinvent (Inst); PharmaMar (Inst); Roche (Inst); Roche (Inst); Sotio (Inst); Tesaro (Inst)
Research Funding - Amgen (Inst); Genmab (Inst); Oncoinvent (Inst); Roche (Inst)
Travel, Accommodations, Expenses - Amgen; AstraZeneca; MSD/Merck; Roche; Tesaro
 
Erika Paige Hamilton
Consulting or Advisory Role - AstraZeneca (Inst); Black Diamond Therapeutics (Inst); Boehringer Ingelheim (Inst); Daiichi Sankyo (Inst); Genentech/Roche (Inst); Lilly (Inst); Mersana (Inst); Novartis (Inst); Pfizer (Inst); Puma Biotechnology (Inst); Silverback Therapeutics (Inst)
Research Funding - Abbvie (Inst); Acerta Pharma (Inst); Aravive (Inst); ArQule (Inst); Arvinas (Inst); AstraZeneca (Inst); BerGenBio (Inst); Black Diamond Therapeutics (Inst); Boehringer Ingelheim (Inst); Clovis Oncology (Inst); Compugen (Inst); Curis (Inst); CytomX Therapeutics (Inst); Daiichi Sankyo (Inst); Deciphera (Inst); eFFECTOR Therapeutics (Inst); Eisai (Inst); EMD Serono (Inst); Fochon Pharmaceuticals (Inst); Fujifilm (Inst); G1 Therapeutics (Inst); Genentech/Roche (Inst); H3 Biomedicine (Inst); Harpoon (Inst); Hutchison MediPharma (Inst); Immunomedics (Inst); InventisBio (Inst); Karyopharm Therapeutics (Inst); Leap Therapeutics (Inst); Lilly (Inst); Lycera (Inst); Macrogenics (Inst); MedImmune (Inst); Medivation (Inst); Mersana (Inst); Merus (Inst); Millennium (Inst); Molecular Templates (Inst); Novartis (Inst); Nucana (Inst); OncoMed (Inst); Orinove (Inst); Pfizer (Inst); Puma Biotechnology (Inst); Radius Health (Inst); Regeneron (Inst); Rgenix (Inst); Seagen (Inst); Sermonix Pharmaceuticals (Inst); Silverback Therapeutics (Inst); Stem CentRx (Inst); Sutter Medical Group (Inst); Syndax (Inst); Syros Pharmaceuticals (Inst); Taiho Pharmaceutical (Inst); Takeda (Inst); TapImmune Inc. (Inst); Tesaro (Inst); Torque (Inst); Torque (Inst); Unum Therapeutics (Inst); Verastem (Inst); Zenith Epigenetics (Inst); Zymeworks (Inst)
Travel, Accommodations, Expenses - Amgen; AstraZeneca; Bayer; Bristol-Myers Squibb; Clovis Oncology; Eisai; EMD Serono; Foundation Medicine; Genentech; Genentech/Roche; Genzyme; Guardant Health; Helsinn Therapeutics; HERON; Lexicon; Lilly; Lilly; Medivation; Merck; Novartis; Pfizer; Roche; Sysmex; Tesaro
 
Ignacio Romero
Consulting or Advisory Role - AstraZeneca; Clovis Oncology; GlaxoSmithKline; Roche
Speakers' Bureau - AstraZeneca; GlaxoSmithKline; PharmaMar; Roche
Research Funding - Roche (Inst)
Travel, Accommodations, Expenses - AstraZeneca; Clovis Oncology; GlaxoSmithKline; PharmaMar; Roche
 
Eva M. Guerra
No Relationships to Disclose
 
Joseph Buscema
Employment - Arizona Oncology
Leadership - Arizona Oncology
Stock and Other Ownership Interests - McKesson
Honoraria - Caris Life Sciences
Consulting or Advisory Role - Caris Life Sciences
 
Annouschka Laenen
No Relationships to Disclose
 
Tamar Perri
No Relationships to Disclose
 
Purificación Estévez-García
Consulting or Advisory Role - AstraZeneca; Clovis Oncology; Tesaro
Speakers' Bureau - AstraZeneca Spain; PharmaMar; Roche
Travel, Accommodations, Expenses - AstraZeneca; PharmaMar; Roche; Tesaro
 
Cesar Gomez Raposo
Consulting or Advisory Role - Tesaro/GSK
Travel, Accommodations, Expenses - Tesaro/GSK
 
Tally Levy
No Relationships to Disclose
 
Giorgio Valabrega
No Relationships to Disclose
 
Jeronimo Martinez Garcia
Consulting or Advisory Role - Amgen; PharmaMar
Travel, Accommodations, Expenses - PharmaMar; Roche
 
Giorgia Mangili
No Relationships to Disclose
 
Vicky Makker
Honoraria - Eisai; Merck; Merck
Consulting or Advisory Role - ArQule; Eisai; Karyopharm Therapeutics; Merck; Takeda
Research Funding - AstraZeneca; Bristol-Myers Squibb; Eisai; Lilly; Merck; Takeda
Travel, Accommodations, Expenses - Eisai; Karyopharm Therapeutics; Merck
Other Relationship - IBM
 
Dayana Michel
Employment - Karyopharm Therapeutics
Travel, Accommodations, Expenses - Karyopharm Therapeutics
 
Hongwei Wang
Employment - Karyopharm Therapeutics; NeuForm (I)
Leadership - NeuForm (I)
Stock and Other Ownership Interests - Curis; Karyopharm Therapeutics; NeuForm
Patents, Royalties, Other Intellectual Property - NeuForm (I)
 
Mansoor Raza Mirza
Leadership - Karyopharm Therapeutics; SeraCare
Stock and Other Ownership Interests - Karyopharm Therapeutics; SeraCare
Honoraria - Advaxis; AstraZeneca; Cerulean Pharma; Clovis Oncology; Novocure; Pfizer; Roche; tesaro
Consulting or Advisory Role - AstraZeneca; BioCad; Cerulean Pharma; Clovis Oncology; Genmab; Karyopharm Therapeutics; Novocure; Pfizer; Sotio; Tesaro
Research Funding - AstraZeneca (Inst); Boehringer Ingelheim (Inst); Clovis Oncology (Inst); Pfizer (Inst); Tesaro (Inst)
Travel, Accommodations, Expenses - AstraZeneca; Karyopharm Therapeutics; Pfizer; Roche; SeraCare; Tesaro